The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, double-blind, placebo-controlled Phase I clinical study
to evaluate the tolerability, safety, and pharmacokinetic characteristics of SIM1910-09 for
injection after single/multiple dosing in healthy Chinese adult volunteers.